CHOLECYSTOKININ-DOPAMINE INTERACTIONS

被引：251

作者：

CRAWLEY, JN

机构：

[1] Behavioral Neuropharmacology, Experimental Therapeutics Branch, National Institute of Mental Health, Bethesda, MD 20892

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1991年 / 12卷 / 06期

关键词：

D O I：

10.1016/0165-6147(91)90558-A

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cholecystokinin (CCK) coexists with dopamine in a large proportion of the ventral tegmental and substantia nigra neurons in rodents and primates. In this review Jacki Crawley integrates the neurophysiological, behavioral, and release studies which demonstrate both excitatory effects of CCK, and facilitatory modulating effects of CCK on the inhibitory actions of dopamine, in the mesolimbic pathway. Nonpeptide antagonists selective for the CCK(A) and CCK(B) receptors have recently been developed, and provide long-awaited tools to test hypotheses about the role of endogenous CCK as a modulator of dopaminergic function, and the potential of CCK-based drugs as treatments for neuropsychiatric disorders.

引用

页码：232 / 236

页数：5

共 50 条

[41]

ROVATI LC, 1988, CHOLECYSTOKININ ANTA, P1

[42] ANALYSIS OF EXPRESSION OF CHOLECYSTOKININ IN DOPAMINE CELLS IN THE VENTRAL MESENCEPHALON OF SEVERAL SPECIES AND IN HUMANS WITH SCHIZOPHRENIA [J].

SCHALLING, M ;

FRIBERG, K ;

SEROOGY, K ;

RIEDERER, P ;

BIRD, E ;

SCHIFFMANN, SN ;

MAILLEUX, P ;

VANDERHAEGHEN, JJ ;

KUGA, S ;

GOLDSTEIN, M ;

KITAHAMA, K ;

LUPPI, PH ;

JOUVET, M ;

HOKFELT, T .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (21) :8427-8431

[43] RESPONSIVENESS OF MESOLIMBIC, MESOCORTICAL, SEPTAL AND HIPPOCAMPAL CHOLECYSTOKININ AND SUBSTANCE-P NEURONAL SYSTEMS TO STRESS, IN THE MALE-RAT [J].

SIEGEL, RA ;

DUKER, EM ;

FUCHS, E ;

PAHNKE, U ;

WUTTKE, W .

NEUROCHEMISTRY INTERNATIONAL, 1984, 6 (06) :783-789

[44]

Stoessl A J, 1989, J Psychopharmacol, V3, P99, DOI 10.1177/026988118900300208

[45] OPPOSITE EFFECTS OF SULFATED CHOLECYSTOKININ ON DA-SENSITIVE ADENYLATE-CYCLASE IN 2 AREAS OF THE RAT NUCLEUS-ACCUMBENS [J].

STUDLER, JM ;

REIBAUD, M ;

HERVE, D ;

BLANC, G ;

GLOWINSKI, J ;

TASSIN, JP .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 126 (1-2) :125-128

[46] CCK-8-IMMUNOREACTIVITY DISTRIBUTION IN HUMAN-BRAIN - SELECTIVE DECREASE IN THE SUBSTANTIA NIGRA FROM PARKINSONIAN-PATIENTS [J].

STUDLER, JM ;

JAVOYAGID, F ;

CESSELIN, F ;

LEGRAND, JC ;

AGID, Y .

BRAIN RESEARCH, 1982, 243 (01) :176-179

[47] NUCLEUS ACCUMBENS CHOLECYSTOKININ (CCK) CAN EITHER ATTENUATE OR POTENTIATE AMPHETAMINE-INDUCED LOCOMOTOR-ACTIVITY - EVIDENCE FOR ROSTRAL-CAUDAL DIFFERENCES IN ACCUMBENS CCK FUNCTION [J].

VACCARINO, FJ ;

RANKIN, J .

BEHAVIORAL NEUROSCIENCE, 1989, 103 (04) :831-836

[48] NEW PEPTIDE IN VERTEBRATE CNS REACTING WITH ANTIGASTRIN ANTIBODIES [J].

VANDERHAEGHEN, JJ ;

SIGNEAU, JC ;

GEPTS, W .

NATURE, 1975, 257 (5527) :604-605

[49] EVIDENCE THAT TYPE-A CCK RECEPTORS FACILITATE DOPAMINE EFFLUX IN RAT-BRAIN [J].

VICKROY, TW ;

BIANCHI, BR ;

KERWIN, JF ;

KOPECKA, H ;

NADZAN, AM .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 152 (03) :371-372

[50] INTERACTIONS OF CHOLECYSTOKININ OCTAPEPTIDE AND DOPAMINE ON NUCLEUS ACCUMBENS NEURONS [J].

WHITE, FJ ;

WANG, RY .

BRAIN RESEARCH, 1984, 300 (01) :161-166

← 1 2 3 4 5 →